After last week’s essay about this disease condition, it has become necessary to help readers understand the peculiar nature of the organ.

Between Friday, May 2, and Saturday, May 10, Washington National Opera will present five evening performances and one Sunday ...

Learn more about whether Merus N.V. or Neurocrine Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The FDA has approved Cabometyx for some patients 12 years old and older with previously treated neuroendocrine tumors.

The FDA has approved Cabometyx (cabozantinib) for previously treated, unresectable, locally advanced or metastatic, well-differentiated neuroendocrine tumors.

well-differentiated pancreatic neuroendocrine tumors (pNET) and well-differentiated extra-pancreatic neuroendocrine tumors (epNET). The approval for use in advanced neuroendocrine tumors is ...

Ethakota, J. , Singh, B. , Bai, S. , Tareen, H. , Kumar, D. and Malik, D. (2025) The Role of Artificial Intelligence in ...

The real-world efficacy of PRRT and its association with tumor functionality and grading in pancreatic neuroendocrine tumors (PanNET) remains underexplored. Methods: A retrospective analysis of 166 ...

2500.HK Venus Medtech (Hangzhou) Inc.